Marcel Verheij
#139,246
Most Influential Person Now
Researcher
Marcel Verheij's AcademicInfluence.com Rankings
Marcel Verheijcomputer-science Degrees
Computer Science
#6581
World Rank
#6939
Historical Rank
Machine Learning
#2186
World Rank
#2214
Historical Rank
Artificial Intelligence
#2453
World Rank
#2494
Historical Rank
Database
#3668
World Rank
#3819
Historical Rank
Download Badge
Computer Science
Marcel Verheij's Degrees
- PhD Computer Science University of Amsterdam
- Masters Artificial Intelligence Utrecht University
- Bachelors Computer Science University of Amsterdam
Similar Degrees You Can Earn
Why Is Marcel Verheij Influential?
(Suggest an Edit or Addition)Marcel Verheij's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis (1996) (1847)
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2022) (908)
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals (1995) (842)
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (811)
- Genome-wide cell-free DNA fragmentation in patients with cancer (2019) (541)
- Ceramide: second messenger or modulator of membrane structure and dynamics? (2003) (415)
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. (2013) (407)
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. (2018) (334)
- Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (312)
- Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. (2010) (210)
- Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway (2003) (206)
- Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) (2011) (205)
- Radiation-induced apoptosis (2000) (198)
- High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. (2003) (161)
- Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis* (2002) (160)
- Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. (1999) (156)
- Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. (2008) (155)
- Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. (2012) (143)
- A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells (2007) (133)
- Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. (2004) (129)
- Anticancer mechanisms and clinical application of alkylphospholipids. (2013) (126)
- Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. (2012) (124)
- In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. (2004) (119)
- Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. (2004) (113)
- Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective (2020) (112)
- In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. (2004) (110)
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer (2020) (108)
- The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine. (2016) (107)
- Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. (1994) (106)
- Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer (2013) (104)
- Optimal locoregional treatment in gastric cancer. (2005) (98)
- The transformation of radiation oncology using real-time magnetic resonance guidance: A review. (2019) (97)
- Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. (2001) (97)
- Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer (2011) (94)
- Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. (2014) (92)
- Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. (2007) (92)
- The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development (2016) (92)
- The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. (1998) (91)
- Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. (2007) (90)
- CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer (2018) (89)
- Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells. (2015) (89)
- ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 (2016) (86)
- Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets (2014) (86)
- Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B (2012) (85)
- Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts. (2007) (84)
- A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study. (2016) (83)
- Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (81)
- Clinical biomarkers and imaging for radiotherapy-induced cell death (2008) (81)
- Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. (2007) (78)
- NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy (2015) (75)
- Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. (2001) (73)
- Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours. (2006) (73)
- Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. (2014) (72)
- R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology (2017) (71)
- Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients (2015) (71)
- Treatment of resectable gastric cancer (2012) (70)
- Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid (2005) (68)
- Centralization of Esophagectomy: How Far Should We Go? (2014) (67)
- Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective. (2010) (67)
- 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy (2007) (65)
- In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma. (2007) (60)
- Radiosensitization of Squamous Cell Carcinoma by the Alkylphospholipid Perifosine in Cell Culture and Xenografts (2006) (57)
- Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab. (2016) (56)
- Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer (2013) (56)
- Interobserver variation of clinical target volume delineation in gastric cancer. (2010) (56)
- AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis (2009) (55)
- The New American Joint Committee on Cancer/International Union Against Cancer Staging System for Adenocarcinoma of the Stomach: Increased Complexity without Clear Improvement in Predictive Accuracy (2012) (54)
- The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). (2019) (53)
- Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway (2008) (53)
- Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors (2011) (53)
- Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. (2001) (51)
- Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. (2005) (51)
- The Prognostic Significance of an R1 Resection in Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy (2014) (49)
- The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. (2002) (49)
- Targeted radiosensitization by the Chk1 inhibitor SAR-020106. (2013) (49)
- Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine. (2003) (49)
- Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. (1994) (48)
- The Effect of Ionizing Radiation on Endothelial Tissue Factor Activity and Its Cellular Localization (1995) (48)
- Imaging strategies in the management of gastric cancer: current role and future potential of MRI. (2019) (48)
- 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome (2008) (48)
- Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects. (1998) (45)
- Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study. (2014) (43)
- Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study (2021) (42)
- Amelioration of radiation nephropathy by acetylsalicylic acid. (1995) (42)
- Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review (2018) (42)
- Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. (2014) (42)
- IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer. (2014) (41)
- Influence of hospital type on outcomes after oesophageal and gastric cancer surgery (2012) (41)
- N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx (2004) (41)
- Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? (2013) (40)
- Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study (2018) (39)
- A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. (2007) (39)
- Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells. (2007) (39)
- TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy. (2006) (38)
- Does Adjuvant Chemoradiotherapy Improve the Prognosis of Gastric Cancer After an R1 Resection? Results from a Dutch Cohort Study (2015) (37)
- Anticancer therapy and apoptosis imaging. (2012) (37)
- Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer (2015) (37)
- Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. (2018) (35)
- Prediction of treatment outcome by cisplatin‐DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin‐radiation (RADPLAT) (2006) (35)
- Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. (2006) (35)
- Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. (2010) (34)
- In Vitro and In Vivo Expression of Endothelial von Willebrand Factor and Leukocyte Accumulation after Fractionated Irradiation (2000) (32)
- Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation (2019) (32)
- Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial (2018) (32)
- Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity (2018) (32)
- Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin (2005) (31)
- The Curative Outcome of Radioimmunotherapy in a Mouse Breast Cancer Model Relies on mTOR Signaling (2014) (31)
- Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma (2016) (31)
- Combining Radiotherapy with APO010 in Cancer Treatment (2009) (30)
- Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib (2019) (30)
- Quality of Care Indicators for the Surgical Treatment of Gastric Cancer: A Systematic Review (2013) (30)
- Radiation nephropathy--the link between functional damage and vascular mediated inflammatory and thrombotic changes. (2001) (29)
- [The Dutch version of 'Functional Status II(R)': a questionnaire measuring the functional health status of children]. (1998) (29)
- Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion (2006) (29)
- Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for Radioprotectors (2016) (29)
- Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases. (2017) (28)
- Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor (2007) (28)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (28)
- Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial. (2020) (28)
- Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial (2017) (28)
- Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy (2007) (28)
- Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents (2008) (27)
- Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer. (2018) (27)
- NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study. (2014) (27)
- Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results from the CRITICS Trial. (2019) (26)
- Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney. (1993) (26)
- Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer. (2015) (26)
- Increased expression of glomerular von Willebrand factor after irradiation of the mouse kidney. (1998) (25)
- Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation (2010) (25)
- Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. (2019) (24)
- Radiation reduces cyclooxygenase activity in cultured human endothelial cells at low doses. (1994) (24)
- Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift. (2017) (23)
- Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance (2013) (22)
- Submicromolar doses of alkyl‐lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cells (2002) (22)
- Towards prediction and modulation of treatment response. (1999) (21)
- [The Dutch 'Rand General Health Rating Index for Children': a questionnaire measuring the general health status of children]. (1998) (21)
- The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. (2019) (20)
- Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer (2019) (20)
- Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation (2020) (20)
- Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas. (2019) (20)
- Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma (2018) (19)
- Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. (2011) (18)
- Translational research offers individually tailored treatments for cancer patients. (2000) (18)
- Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency. (2009) (18)
- Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity. (2017) (17)
- Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy. (2017) (17)
- Radiotherapy dose and fractionation for stage III NSCLC. (2015) (17)
- Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial. (2020) (16)
- Sphingolipids related to apoptosis from the point of view of membrane structure and topology. (2001) (16)
- Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials. (2017) (16)
- Imaging Radiotherapy-Induced Apoptosis (2012) (16)
- Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study (2015) (16)
- Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. (2012) (15)
- Improving Intracellular Doxorubicin Delivery Through Nanoliposomes Equipped with Selective Tumor Cell Membrane Permeabilizing Short-Chain Sphingolipids (2013) (14)
- Alkyl-lysophospholipids activate the SAPK/JNK signaling pathway and enhance radiation-induced apoptosis (1999) (14)
- Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy (2019) (14)
- Extended lymph node dissection for gastric cancer from a European perspective (2011) (14)
- LBA-02A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: first results from the CRITICS study (2016) (13)
- Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck (2018) (13)
- Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cells. (2011) (12)
- Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model. (2015) (12)
- Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position. (2020) (11)
- Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. (2020) (11)
- Short-Chain Glycoceramides Promote Intracellular Mitoxantrone Delivery from Novel Nanoliposomes into Breast Cancer Cells (2014) (11)
- Radiation-induced von Willebrand factor release. (1997) (11)
- Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. (2022) (11)
- Tumour deposits are a significant prognostic factor in gastric cancer – a systematic review and meta‐analysis (2019) (11)
- Drug sensitivity prediction models reveal a link between DNA repair defects and poor prognosis in HNSCC. (2019) (11)
- Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients (2019) (11)
- To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer (2021) (11)
- Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ (2021) (11)
- Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer (2020) (10)
- A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting (2015) (10)
- The Essentials of Locoregional Control in the Treatment of Gastric Cancer (2006) (10)
- Late follow‐up of the randomized radiation and concomitant high‐dose intra‐arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer (2016) (10)
- Mesothelioma cells depend on the anti-apoptotic protein Bcl-xL for survival and are sensitized to ionizing radiation by BH3-mimetics. (2019) (9)
- Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlook. (2014) (9)
- Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours (2018) (9)
- Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results. (2019) (9)
- The Influence of a Multi-disciplinary Meeting for Quality Assurance on Target Delineation in Radiotherapy Treatment Preparation (2009) (9)
- Randomized trials and quality assurance in gastric cancer surgery (2013) (9)
- Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model (2017) (9)
- Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients. (2003) (8)
- Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of 99mTc-Hynic-rh-Annexin V Imaging (2008) (8)
- Towards Personalization in the Curative Treatment of Gastric Cancer (2020) (8)
- A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy (2020) (7)
- Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients (2019) (7)
- Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial (2018) (7)
- Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. (2012) (7)
- Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer? (2012) (7)
- Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials (2022) (6)
- Immunofluorescence detection of herpes simplex virus type 1 antigen in cerebrospinal fluid cells of experimentally infected mice (1988) (6)
- Functional Imaging in Radiotherapy in the Netherlands: Availability and Impact on Clinical Practice. (2016) (6)
- The effect of age in breast conserving therapy: a retrospective analysis on pathology and clinical outcome data. (2015) (6)
- Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial. (2018) (6)
- Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial (2020) (6)
- C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake. (2015) (6)
- A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy. (2012) (5)
- Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma (2020) (5)
- Membrane organization determines barrier properties of endothelial cells and short-chain sphingolipid-facilitated doxorubicin influx. (2014) (5)
- Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study (2022) (5)
- Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors. (2004) (4)
- Hospital variance in neoadjuvant rectal cancer treatment and the influence of a national guideline update: Results of a nationwide population-based study. (2020) (4)
- Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy (2021) (4)
- Implementation Of MR-Linac And Proton Therapy In Two Radiotherapy Departments In The Netherlands: Recommendations Based On Lessons Learned. (2021) (4)
- Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial (2021) (4)
- Cetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: A feasibility study (2011) (4)
- Predicting Early Chemotherapy Response with Technetium-99m Methoxyisobutylisonitrile SPECT/CT in Advanced Non-Small Cell Lung Cancer (2010) (4)
- MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy? (2021) (4)
- Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial. (2022) (3)
- Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system (2020) (3)
- Regarding Maor et al. IJROBP 41:647-650; 1998. (1999) (3)
- Methodological aspects and applications of in vivo imaging of apoptosis in oncology: An illustrative review (2005) (3)
- Adverse event development in clinical oncology trials. (2016) (3)
- Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticles. (2020) (3)
- Micro cone beam computed tomography for sensitive assessment of radiation-induced late lung toxicity in preclinical models. (2019) (2)
- Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer (2013) (2)
- Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association (2018) (2)
- Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study. (2016) (2)
- Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review (2021) (2)
- Circulating tumor DNA dynamics in resectable gastric cancer. (2018) (2)
- Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study (2018) (2)
- Emerging issues in multimodality treatment of gastric cancer (2015) (2)
- Preoperative chemoradiotherapy (CRT) in gastric cancer. (2013) (2)
- Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer. (2018) (2)
- Selective tumor cell kill by alkyl-lysophospholipids (1999) (2)
- [New insights in the adjuvant treatment of gastric cancer]. (2004) (2)
- OC-0617: The PARP inhibitor olaparib is effective as radiosensitizer at 10-fold lower doses than as single agent (2015) (2)
- Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply. (2018) (2)
- OC-0487: EMT signatures as a prognostic marker for metastasis in HPV-negative HNSCC (2018) (2)
- OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL (2012) (2)
- Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts. (2022) (2)
- Patterns of recurrence to guide selection of multi-modal treatment. (2018) (1)
- 15 Apoptosis-enhancing agents and radiotherapy (2006) (1)
- Radiation and anti-cancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP down- regulation (2010) (1)
- Postoperative Chemoradiotherapy in Gastric Cancer - Results of Two Parallel Phase I-II Studies of a Fixed Radiotherapy Regimen with Escalating Doses of Cisplatin and Capecitabine (2005) (1)
- Erratum to “IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer” [Radiother. Oncol. 112 (2014) 289–294] (2015) (1)
- Results of phase I trials combining PARP inhibition and radiotherapy in multiple sites (2016) (1)
- The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patients. (2020) (1)
- Induction of skalp/elafin gene expression in cultured human keratinocytes by inflammatory cytokines (1998) (1)
- A comparison of elderly versus nonelderly patients in the CRITICS gastric cancer trial. (2019) (1)
- 109 Cisplatin-DNA adduct measurements in head and neck cancer patients treated by chemoradiotherapy (2003) (1)
- Comparison of SUVs based on different ROIs and VOIs definitions: a multicenter respiratory phantom study (2016) (1)
- PO-0904: Development of an MRI-protocol for radiotherapy treatment guidance in gastric cancer (2017) (1)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (1)
- 234 Gossypol, a small molecule inhibitor of BCL-2, increases radiation-induced cytotoxicity in human prostate and head and neck cancer cells (2006) (1)
- Genome-wide cell-free DNA fragmentation in patients with cancer (2019) (1)
- Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. (2023) (1)
- Immuno-Radiotherapy with Cetuximab and Avelumab for Advanced Stage Head and Neck Squamous Cell Carcinoma: Results from a Phase-IB Trial (2019) (1)
- Reply to F. Sclafani et al (2010) (1)
- ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies. (2021) (1)
- 710 In vivo assessment of radiation induced apoptosis in follicular lymphoma patients by 99mTc-Annexin V scintigraphy (2003) (1)
- Results of a comparison between European countries for esophagectomy and gastrectomy: Initiative for a European upper GI audit (EURECCA Upper GI). (2012) (1)
- [Shared decision-making becoming increasingly important]. (2015) (1)
- Alkyl-lysophospholipids enhance radiation-induced cytotoxicity and inhibit angiogenesis in vitro (2001) (1)
- Radiation Therapy in Gastric Cancer (2018) (1)
- CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer (2018) (1)
- Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial (2021) (1)
- Abstract 4025: SHIP-1 is involved in resistance to alkyl-lysophospholipid induced apoptosis in S49 T-cell lymphoma cells (2010) (1)
- Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib (2019) (0)
- SP-0567: The new 'R's; in radiation biology (2016) (0)
- New aspects of sphingolipids in relation to apoptosis (2001) (0)
- In Vivo Imaging of Apoptosis by Annexin V Scintigraphy: Predictive Value for Treatment Outcome (2007) (0)
- Surgicopathological quality control in the CRITICS gastric cancer trial (2017) (0)
- Lipid rafts as novel targets for anti-cancer therapy and induction of apoptosis (2005) (0)
- PO-0694: Radiation dose-dependent changes of the spleen following chemoradiotherapy for gastric cancer (2015) (0)
- Abstract C009: Clinical pharmacokinetic and pharmacodynamic analyses support biological effectivity of the PARP inhibitor olaparib as radiosensitizer at low doses (2019) (0)
- TRIP12 Governs DNA Polymerase β Involvement in DNA Damage Response and Repair (2020) (0)
- 165 oral POSTOPERATIVE CHEMORADIOTHERAPY IMPROVES SURVIVAL AFTER D1 LYMPHADENECTOMY OR R1 RESECTION IN GASTRIC CANCER (2011) (0)
- Inductie van apoptose door alkyl-lysofosfolipiden en verwante antitumor-agentia. (1999) (0)
- 6502 ORAL Preoperative Chemotherapy Does Not Influence the Number of Evaluable Lymph Nodes in Resected Gastric Cancer (2011) (0)
- [Radiotherapy in Europe]. (2016) (0)
- Pharmaceutical formulations that use short chain sphynolipids and uses of the same. (2004) (0)
- OC-0463: In vitro prediction of DNA repair defects reveals association with poor clinical outcome in HNSCC (2017) (0)
- Radiation Oncology in The Netherlands. (2018) (0)
- Patterns of Recurrence after Postoperative Chemoradiotherapy in Gastric Cancer (2009) (0)
- Postoperative Chemoradiotherapy Improves Survival after D1 Lymphadenectomy or R1 Resection in Gastric Cancer (2010) (0)
- The prognostic value of tumor markers in patients (pts) with resectable gastric cancer (GC) receiving perioperative therapy in the CRITICS trial. (2021) (0)
- OC-0246: Screening on aided drug-membrane traversal identifies PI3K inhibitors as targets for improved radiosensitization (2014) (0)
- OC-0411 The prognostic value of tumor markers in patients with resectable gastric cancer (2021) (0)
- PO-0662: Planning according to plan: quality assurance in a randomized international multicenter phase II trial (2013) (0)
- Conditional survival nomogram after an R0 resection for gastric cancer. (2011) (0)
- PO-0977: Assessment of motion and SUV recovery in 3D and 4D PET/CT: a multicentre phantom study (2018) (0)
- Abstract 2761: Co-administration of the short-chain sphingolipid N-octanoyl-glucosylceramide improves doxorubicin therapy by enhancing intracellular drug accumulation in vivo (2012) (0)
- 170 Clinical biomarkers and imaging for radiotherapy-induced cell death (2009) (0)
- 351 Sensitive pharmacodynamic assessment of PARP inhibitors for individualized treatment in clinic (2015) (0)
- 1004 POSTER In vivo imaging of apoptosis by Annexin V scintigraphy: predictive value for treatment outcome (2007) (0)
- Poster ViewingDefinitive (Chemo)Radiation Therapy is a Curative Alternative for Standard of Care in Advanced Stage Squamous Cell Carcinoma of the Oral Cavity (2017) (0)
- Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model (2020) (0)
- SP-0390: Radiotherapy and targeted drugs: which and how many pathway(s) to target? (2013) (0)
- Abstract 5454: New insights into the mode of action of cytotoxic alkyl-phospholipids (2018) (0)
- Radiation response and apoptosis (2001) (0)
- Obituary: Adrian C. Begg. (2014) (0)
- SP-0452 Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity (2019) (0)
- Perioperative Therapy with Postoperative Chemoradiotherapy in the Critics Gastric Cancer Trial: A Comparison of Elderly Versus Non-Elderly Patients (2019) (0)
- Improvement of chemoradiation response in head and neck cancer by (-)Gossypol (AT-101), a small molecule inhibitor of Bcl-XL/Bcl-2 (2007) (0)
- clinical practice guidelines Gastric cancer : ESMO Clinical Practice Guidelines for diagnosis , treatment and follow-up (2010) (0)
- Abstract 3382: Formation of transient membrane channels targets doxorubicin resistance. (2013) (0)
- ASO Visual Abstract: Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective, Cohort Study. (2023) (0)
- NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy (2015) (0)
- SP-0370: Radiotherapy (2014) (0)
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer: per protocol analysis of the CRITICS trial (2019) (0)
- 2645 : Gossypol Activates the SAPK/JNK Pathway and Enhances Radiation-Induced Apoptosis (2006) (0)
- OC-0438: Clinical pharmacodynamics support biological effectivity of low dose olaparib as radiosensitizer (2020) (0)
- Acute Toxicity and Post-operative Complications of Preoperative Chemoradiotherapy with Capecitabine followed by Surgery for Locally Advanced Rectal Cancer (2010) (0)
- Using BRCA1/2-Deficient Mouse Mammary Tumors and μIGRT to Investigate Underlying Mechanisms Causing Radioresistance (2013) (0)
- OC-0051: Towards the clinic: application of μ-IGRT for assessment of radiationinduced pneumonitis and pulmonary fibrosis (2014) (0)
- Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice? (2001) (0)
- EP-1160 Increasing radiotherapy responsiveness of mesothelioma by activating tumour specific cell death (2015) (0)
- Novel anti-tumour agents targeting the cell membrane (2016) (0)
- Reply to Patel et al. ‘Mucinous differentiation of rectal cancers: does it really impact oncological outcomes?’ (2021) (0)
- OC-0487: Genetically engineered breast cancer mouse models to explore and target radioresistance (2014) (0)
- Gastric cancer (cid:2) : ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up q (2014) (0)
- P0-42: Targeting NAD+ Biosynthesis Combined with Radiation to Enhance Cell Death (2012) (0)
- 78. Surgicopathological quality control in the CRITICS gastric cancer trial (2016) (0)
- Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study. (2023) (0)
- OC-0107 Randomised phase 2 trial of preop chemo(radio)therapy in gastric cancer: CRITICS-II interim results (2022) (0)
- Pharmaceutical formulations with short-chain sphingolipids and their use (2004) (0)
- MO-0219 Quality assurance of preoperative radiotherapy in the CRITICS-II gastric cancer trial (2022) (0)
- OC-0692: Phase 1 study of olaparib as radiosensitizer for locally advanced non-small cell lung cancer (2020) (0)
- 300 ORAL Lipid rafts as novel targets for anti-cancer therapy (2007) (0)
- Abstract 354: Mucinous phenotype is associated with response to neoadjuvant chemotherapy in microsatellite instable resectable gastric cancer (2021) (0)
- EP-1435 VOLUMETRIC-MODULATED ARC THERAPY FOR STEREOTACTIC ABLATIVE RADIOTHERAPY OF ADRENAL GLAND METASTASES (2012) (0)
- SP-0643: RT-drug combinations: Targeted radiosensitisation (2018) (0)
- Short-chain sphingolipids for enhanced cellular uptake of amphiphilic anti-cancer drugs (2008) (0)
- 6633 POSTER Conditional Probability of Survival Nomogram After an R0 Resection for Gastric Cancer (2011) (0)
- 325 POSTER Gossypol activates the SAPK/JNK pathway and enhances radiation-induced apoptosis (2007) (0)
- PD-0570 NOMOGRAM PREDICTING SURVIVAL AFTER R0 GASTRECTOMY: VALIDATION IN PATIENTS WITH POSTOPERATIVE CHEMORADIATION (2012) (0)
- PO-0967: Quality assurance of 4DCT in the EORTC Lungtech trial on SBRT for patients with NSCLC (2018) (0)
- Abstract 1462: Targeting NAD+biosynthesis combined with radiation to enhance cell death (2012) (0)
- PO-0758: Modelling radiotherapy escape using BRCA1/2-def mouse mammary tumors and image-guided irradiation (2013) (0)
- Induction of apoptosis by alkyl-lysophospholipids and related antitumor agents. (1999) (0)
- Abstract 4438: A membrane modulating strategy improves doxorubicin therapy in spontaneous mouse breast carcinoma (2011) (0)
- EP-1439: MRI-based clinical target volume delineation in gastric cancer: first results of a feasibility study (2018) (0)
- UvA-DARE Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer (2015) (0)
- The new 'R's; in radiation biology (2016) (0)
- PD-0426: Homologous recombination repair deficient tumor cells exhibit increased radiosensitization by PARP inhibition (2014) (0)
- EP-1392 Preoperative image-guided identification of response to nCRT in esophageal cancer (PRIDE study) (2019) (0)
- EP-1383: The use of Real World Evidence to audit NTCP-models for acute esophagus toxicity in NSCLC patients (2018) (0)
- Pathways and time effect of radiation-induced apoptosis (1997) (0)
- EP-1716: Prospective electronic toxicity registration to audit NTCP models and dose constraints (2016) (0)
- PO-1049: HNSCC Cell Lines with DNA Repair Defects show an Invasive Phenotype in vitro (2018) (0)
- Improving Intracellular Doxorubicin Delivery Through Nanoliposomes Equipped with Selective Tumor Cell Membrane Permeabilizing Short-Chain Sphingolipids (2013) (0)
- 99MTC hynic-RH-annexin V scintigraphy for in vivo imaging of apoptosis in patients with advanced head and neck cancer treated with concurrent cisplatin and radiotherapy (2007) (0)
- 74 How do we choose new molecular targets for clinical exploitation (2003) (0)
- Raft Lipid Metabolism in Relation to Alkyl-Lysophospholipid-Induced Apoptosis (2005) (0)
- 339 POSTER Improved in vitro and in vivo anti-tumor efficacy of glucosylceramide-enriched liposomal doxorubicin (2007) (0)
- Identification of genes involved in resistance of prostate cancer cells to irradiation (2009) (0)
- [The concomitant use of radiotherapy and chemotherapy for the treatment of solid malignant tumors]. (2002) (0)
- Locally recurrent rectal cancer: towards a second chance at cure? (2023) (0)
- Abstract 4434: Identification of radiation susceptibility genes in prostate cancer by whole genome RNA interference screening. (2013) (0)
- ALP-inducedALP-induced EGFR internalization SUBMICROMOLARR DOSES OF ALKYL-LYSOPHOSPHOLIPIDS INDUCE RAPID INTERNALIZATION ,, BUT NOT ACTIVATION, OF EPIDERMAL GROWTH FACTORR RECEPTOR AND CONCOMITANT MAPK/ERK ACTIVATION INN A431 CELLS (2007) (0)
- OC-0068 THE NAD+ DEPLETING AGENT APO866 ENHANCES CELL DEATH WHEN COMBINED WITH RADIATION (2012) (0)
- PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer (2022) (0)
- RANDOMIZED TRIALS FOR RESECTABLE GASTRIC CANCER Extent of Lymph Node Dissection (2012) (0)
- Resistance to alkyl-lysophospholipid- and CD95/FAS-induced apoptosis in S49 lymphoma cells associated with downregulated SMS1 and SHIP1 (2008) (0)
- Abstract C31: NAMPT inhibition combined with radiation enhances cell death in a prostate cancer model (2012) (0)
- Abstract 5527: Short-chain glucosylceramide improves doxorubicin delivery in spontaneous mouse breast carcinomas (2010) (0)
- PD-0427: A pharmacodynamic assay to assess the radiosensitizing potential of PARP inhibitors in clinical trials (2014) (0)
- Evaluation of innovation in radiation oncology: R-IDEAL (2016) (0)
- Patterns of recurrence in the CRITICS gastric cancer trial: results from intention-to-treat and per-protocol analyses (2019) (0)
- Sphingomyelin Content Determines Sensitivity to Radiation in Mouse S49 Lymphoma Cells (2008) (0)
- Risk factors of metachronous peritoneal carcinomatosis after potentially curative gastric cancer resection in the CRITICS trial. (2021) (0)
- Postoperative chemoradiotherapy in gastric cancer: results of two parallel phase I???II studies of a fixed radiotherapy regimen with escalating doses of cisplatin and capecitabine (2006) (0)
- Impact of TRAIL death receptor trafficking on pro-apoptotic signaling (2008) (0)
- Abstract 2750: Short-chain lipids catalyse intracellular drug accumulation by a transient molecular gateway that allows plasma membrane traversal (2012) (0)
- OC-0475 THE USE OF IMRT REDUCES LATE NEPHROTOXICITY AFTER CHEMORADIOTHERAPY FOR GASTRIC CANCER (2012) (0)
- SP-0607: microRNAs and radioresistance in head and neck cancer (2014) (0)
- 208: The ART of translation (2014) (0)
- Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer (2022) (0)
- CD95/Fas downregulation in lymphoma cells through acquired alkyl-lysophospholipid resistance; partial role of associated sphingomyelin deficiency (2020) (0)
- 217 Tumor therapy with ionizing radiation and death ligands: Efficacy and key molecular determinants (2006) (0)
- OC-0168: Patterns of recurrence in the CRITICS gastric cancer phase III trial (2018) (0)
- Prediction of Outcome by Cisplatin DNA-adduct Formation in Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma, Treated by Concurrent Cisplatin-Chemoradiation (RADPLAT) (2005) (0)
- 1001 Apoptosis, proliferation and P53, cyclin D1 and retinoblastoma gene expression in relation to radiation response in muscle-invasive bladder cancer (1999) (0)
- 169: Homologous recombination deficiency and radio-curability in mouse models for BRCA1/2-deficient breast cancer (2014) (0)
- OC-0040: Validation of prospective electronic toxicity registration to audit dose constraints (2017) (0)
- The effect of preoperative chemotherapy on lymph node yield in gastric cancer. (2011) (0)
- Diffuse Gastric Cancer (2009) (0)
- 222 Apoptosis modulation from bench to bedside: Radiosensitization by the oral alkylphospholipid perifosine (2006) (0)
- SP-0418 MULTIDISCIPLINARY MANAGEMENT OF OPERABLE GASTRIC CANCER (2012) (0)
- Dose coverage and breath-hold analysis of breast cancer patients treated with surface-guided radiotherapy (2023) (0)
- Short-Chain Glycoceramides Promote Intracellular Mitoxantrone Delivery from Novel Nanoliposomes into Breast Cancer Cells (2014) (0)
- P2.14-020 Clinical Validation of NTCP-Models for Esophagus Toxicity in Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiation (2017) (0)
- low-dose radiotherapy in follicular lymphoma In vivo p53 response and immune reaction underlie highly effective (2013) (0)
- In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care (2017) (0)
- OC-0539: A multicentre QA study on 4DCT and IMRT/VMAT techniques for lung SBRT using a respiratory phantom (2017) (0)
- 2156 : Patterns of Recurrence in Adenocarcinoma of the Stomach After Postoperative Chemoradiotherapy (2006) (0)
- Poster: Clinical track: Treatment preparation and deliveryPO-0791: Interpretation of uncertainty scenarios for head and neck IMPT treatment plans using TCP and NTCP models (2015) (0)
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer (2020) (0)
- Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial. (2018) (0)
- Genetically Enigineered Mouse Models and High Precision Fractionated Radiation Therapy to Unravel Mechanisms of Irradiation Escape (2014) (0)
- Short-chain sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs (2010) (0)
- Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer (2015) (0)
- Radiation-induced biochemical changes of human endothelial cells (1992) (0)
- OC-0483: DNA repair defects in squamous cell carcinomas of the head and neck (2014) (0)
- A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting (2015) (0)
- 101. Quality of care indicators for the surgical treatment of gastric cancer (2012) (0)
- EP-1682: Comparison of SUV based on different ROIs and VOIs definitions: a multi-center 4D phantom study (2017) (0)
- PO-1060: Combining radiation with the pan-Bcl-2 inhibitor AT-101: in vitro studies and clinical pharmacokinetics in HNSCC (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marcel Verheij?
Marcel Verheij is affiliated with the following schools:
